Notice of Effectiveness (effect)
2018年3月22日 - 7:01PM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
March 21,
2018
|
|
Accession Number:
|
0001193125-18-076341
|
|
Submission Type:
|
POS AM
|
|
CIK:
|
0001412067
|
|
Company Name:
|
Cascadian Therapeutics, Inc.
|
|
File Number:
|
333-201317
|
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
過去 株価チャート
から 4 2024 まで 5 2024
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Cascadian Therapeutics, Inc. (delisted) (ナスダック市場): 0 recent articles
その他のCascadian Therapeutics, Inc.ニュース記事